Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
INKT MiNK Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: INKT
Price (delayed)
$7.54
Market cap
$29.91M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.86
Enterprise value
$30.25M
Highlights
INKT's EPS has surged by 56% year-on-year and by 26% since the previous quarter
MiNK Therapeutics's net income has surged by 52% YoY and by 22% QoQ
MiNK Therapeutics's quick ratio has soared by 120% YoY but it has decreased by 23% from the previous quarter
MiNK Therapeutics's equity has decreased by 12% from the previous quarter and by 8% YoY
The debt has grown by 7% from the previous quarter
Key stats
What are the main financial stats of INKT
Market
Valuations
Earnings
Shares outstanding
3.97M
Market cap
$29.91M
Enterprise value
$30.25M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$11.29M
Net income
-$10.78M
EBIT
-$10.78M
EBITDA
-$10.57M
Free cash flow
-$9.56M
Per share
Balance sheet
Liquidity
EPS
-$2.86
EPS diluted
-$2.86
Free cash flow per share
-$2.53
Book value per share
-$4.95
Revenue per share
$0
TBVPS
$1.52
Total assets
$5.72M
Total liabilities
$25.31M
Debt
$4.92M
Equity
-$19.59M
Working capital
-$1.97M
Debt to equity
-0.25
Current ratio
0.72
Quick ratio
0.66
Net debt/EBITDA
-0.03
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-142.3%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INKT stock price
How has the MiNK Therapeutics stock price performed over time
Intraday
5.01%
1 week
7.25%
1 month
-3.7%
1 year
-27.5%
YTD
8.18%
QTD
-12.73%
Financial performance
How have MiNK Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$11.29M
Net income
-$10.78M
Gross margin
N/A
Net margin
N/A
MiNK Therapeutics's net income has surged by 52% YoY and by 22% QoQ
INKT's operating income has soared by 51% YoY and by 21% QoQ
Price vs fundamentals
How does INKT's price correlate with its fundamentals
Growth
What is MiNK Therapeutics's growth rate over time
Valuation
What is MiNK Therapeutics stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
INKT's EPS has surged by 56% year-on-year and by 26% since the previous quarter
MiNK Therapeutics's equity has decreased by 12% from the previous quarter and by 8% YoY
Efficiency
How efficient is MiNK Therapeutics business performance
MiNK Therapeutics's ROA has increased by 35% YoY and by 25% from the previous quarter
Dividends
What is INKT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INKT.
Financial health
How did MiNK Therapeutics financials performed over time
The total assets is 77% lower than the total liabilities
INKT's current ratio has soared by 125% year-on-year but it is down by 19% since the previous quarter
MiNK Therapeutics's quick ratio has soared by 120% YoY but it has decreased by 23% from the previous quarter
The debt is 125% more than the equity
MiNK Therapeutics's equity has decreased by 12% from the previous quarter and by 8% YoY
The debt has grown by 7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.